LifeVantage joins with Cornerstone R&D
This article was originally published in The Tan Sheet
Executive Summary
San Diego, Calif.-based nutraceutical firm LifeVantage Corporation teams with Utah-based Cornerstone Research and Development firm to cut product manufacturing costs significantly, LifeVantage says in an Aug. 21 release. The merger will cut in half the costs for manufacturing LifeVantage's anti-oxidant therapy Protandim, the firm's President and CEO David Brown says. LifeVantage also points out Cornerstone's good manufacturing practice certification will boost business opportunities for the firm
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.